ESSENTIAL HYPERTENSION
Clinical trials for ESSENTIAL HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new ESSENTIAL HYPERTENSION trials appear
Sign up with your email to follow new studies for ESSENTIAL HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to tame high blood pressure better than current standard
Disease control Recruiting nowThis large Phase 3 trial is testing whether a new combination drug called CKD-202A works better than a common standard medication (valsartan) at lowering high blood pressure. It will involve 324 adults with essential hypertension. The study is designed to see if the new drug prov…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: PHASE3 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Decade-Long hunt for childhood hypertension genes begins
Knowledge-focused Recruiting nowThis study aims to discover the genetic causes of high blood pressure that starts in childhood. Researchers will follow over 2,300 children, adults who had it as kids, and their healthy relatives for up to 10 years, collecting blood, urine, and health data. The goal is to map the…
Matched conditions: ESSENTIAL HYPERTENSION
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Apr 01, 2026 21:56 UTC
-
New blood pressure drug tested on healthy volunteers
Knowledge-focused Recruiting nowThis is a very early study to see if a new drug called BCD101 is safe for people and how it moves through the body. It will involve 56 healthy adults who will receive either the drug or a placebo (inactive substance) in increasing doses. The main goal is to check for side effects…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: PHASE1 • Sponsor: Bichedam Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC